Home > PS Ratio > DIVIS LABORATORIES

DIVIS LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of DIVIS LABORATORIES is 17.33.

Share Price ₹5,622.3Feb 01,2025
Market Cap ₹149,272.1 Cr
Sales-TTM₹8,614.0 CrTTM-Consolidated Results
Price/Sales17.33xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of DIVIS LABORATORIES is calculated as :

Current Market Cap [ ₹149,272.1 Cr] as on Feb 01,2025

(/) Sales [ ₹8,614.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 17.33x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '17.33 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !

The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES


PS Ratio Performance Analysis for DIVIS LABORATORIES

- DIVIS LABORATORIES 's latest p/e ratio is 17.33x.

- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.58x.

- DIVIS LABORATORIES 's operated at median p/e ratio of 11.61x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2021 at 13.83x.

- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.


How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
DIVIS LABORATORIES 8,614.017.33149,272.1
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.58.10418,132.0
CIPLA LTD26,981.24.30116,123.0
DR REDDYS LABORATORIES LTD31,229.33.22100,573.0
ZYDUS LIFESCIENCES LTD21,483.54.5697,966.9
MANKIND PHARMA LTD11,641.08.79102,348.0
TORRENT PHARMACEUTICALS LTD11,302.09.60108,477.0
LUPIN LTD21,431.34.3893,813.7
AUROBINDO PHARMA LTD30,295.02.1966,385.6
ABBOTT INDIA LTD6,066.19.0855,059.0
ALKEM LABORATORIES LTD12,706.24.7360,079.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.19x
Max industry PS 17.33x
Median industry PS 4.73x
Average industry PS 6.93x



You may also like the below Video Courses